Endowments provide faculty with freedom and flexibility to pursue critical research endeavors
Aug. 14, 2018
| By Kristen Woodward / Fred Hutch News Service
Hematologist Dr. Geoffrey Hill, a physician-scientist who was recently recruited from Australia to lead Hematopoietic Stem Cell Transplantation at Fred Hutch, is the third and most recent recipient of the José Carreras/E. Donnall Thomas Endowed Chair for Cancer Research.
$20M renewal of 4-decade-long federal grant to Hutch scientists
May 31, 2018
| By Susan Keown / Fred Hutch News Service
The National Cancer Institute has awarded Hutch with five years and nearly $20 million in funding for research to develop better therapies for people with blood cancers. The award is the latest renewal of a grant that has been funded continuously for more than 40 years.
Dr. Geoffrey Hill will help integrate bone marrow transplantation with emerging cancer immunotherapies
Dec. 7, 2017
| By Molly McElroy
Fred Hutchinson Cancer Research Center is appointing world-renowned blood stem cell transplantation physician-scientist Dr. Geoffrey Hill to be director of Hematopoietic Stem Cell Transplantation, effective July 1.
Fred Hutch is proud to be an Equal Opportunity and VEVRAA Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability, marital or veteran status, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. Read the EEO is the Law poster here.